|
Name |
1-Acetyl-2-picolinoylhydrazine
|
Molecular Formula | C8H9N3O2 | |
IUPAC Name* |
N'-acetylpyridine-2-carbohydrazide
|
|
SMILES |
CC(=O)NNC(=O)C1=CC=CC=N1
|
|
InChI |
InChI=1S/C8H9N3O2/c1-6(12)10-11-8(13)7-4-2-3-5-9-7/h2-5H,1H3,(H,10,12)(H,11,13)
|
|
InChIKey |
FDJAMXYLIRPRIS-UHFFFAOYSA-N
|
|
Synonyms |
Azapicyl; 1-Acetyl-2-picolinoylhydrazine; N'-acetylpyridine-2-carbohydrazide; 17433-31-7; 2-Pyridinecarboxylic acid, 2-acetylhydrazide; Hydrazine, 1-acetyl-2-picolinoyl-; 1-Acetyl-2-picolinolhydrazine; NSC 68626; NSC-68626; NCI-C04739; N-Acetyl-N'-isonicotinyl hydrazide; P-2292; 1-ACETYL-2-PICOLINOYL HYDRAZINE; 186TH42ZNH; 1-Acetyl-2-(.alpha.-picolinoyl)hydrazine; N'-Acetylpicolinohydrazid; CCRIS 5882; BRN 0392704; NCIOpen2_000563; UNII-186TH42ZNH; ZINC980; CHEMBL475125; DTXSID2024408; N-acetyl-N'-(2-pyridoyl)hydrazine; NSC68626; CCG-55199; STK092045; N'-Acetyl-2-pyridinecarbohydrazide #; AKOS005394909; SR-01000644238-1; PYRIDINE-2-CARBOXYLIC ACID N'-ACETYL-HYDRAZIDE
|
|
CAS | 17433-31-7 | |
PubChem CID | 28545 | |
ChEMBL ID | CHEMBL475125 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 179.18 | ALogp: | -0.6 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 71.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.608 |
Caco-2 Permeability: | -4.366 | MDCK Permeability: | 0.00001750 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.01 |
Blood-Brain-Barrier Penetration (BBB): | 0.999 | Plasma Protein Binding (PPB): | 18.21% |
Volume Distribution (VD): | 0.579 | Fu: | 75.05% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.134 |
CYP2C19-inhibitor: | 0.034 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.22 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.089 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.14 |
Clearance (CL): | 4.491 | Half-life (T1/2): | 0.653 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.738 |
Drug-inuced Liver Injury (DILI): | 0.979 | AMES Toxicity: | 0.063 |
Rat Oral Acute Toxicity: | 0.118 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.286 | Carcinogencity: | 0.342 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.85 |
Respiratory Toxicity: | 0.054 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000485 | 0.488 | D0GY5Z | 0.315 | ||||
ENC000056 | 0.488 | D0I2VK | 0.308 | ||||
ENC000717 | 0.328 | D05OFX | 0.303 | ||||
ENC000073 | 0.315 | D0G2MH | 0.293 | ||||
ENC004871 | 0.306 | D08EBN | 0.288 | ||||
ENC001012 | 0.300 | D07ONP | 0.286 | ||||
ENC000192 | 0.298 | D0I6IB | 0.276 | ||||
ENC000693 | 0.296 | D02AQY | 0.276 | ||||
ENC000391 | 0.286 | D0SH3I | 0.267 | ||||
ENC001033 | 0.286 | D00IBN | 0.266 |